Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

TeamTRACS Pilot (CTSI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05370157
Recruitment Status : Enrolling by invitation
First Posted : May 11, 2022
Last Update Posted : June 14, 2022
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Elizabeth McGuier, University of Pittsburgh

Brief Summary:
In a previous research study, the investigators adapted an evidence-based team training intervention for healthcare settings (TeamSTEPPS) to fit the needs and context of Child Advocacy Center multidisciplinary teams. This study is a cluster-randomized controlled trial of the adapted training, TeamTRACS (Team Training in Roles, Awareness, Communication, and Support). This hybrid type 2 effectiveness-implementation study will test the effectiveness of TeamTRACS and pilot a self-guided approach to implementing TeamTRACS in low-resource settings.

Condition or disease Intervention/treatment Phase
Teamwork Implementation Behavioral: TeamTRACS Not Applicable

Detailed Description:
This study is designed to test the effects of TeamTRACS on knowledge, skill use, and team functioning. It will also evaluate the acceptability, appropriateness, and feasibility of a self-guided implementation approach that requires few resources and builds local capacity for change. Six rural Child Advocacy Centers (CACs) will be randomized to TeamTRACS (4 CACs) or a waitlist comparison (2 CACs). The long-term goal of this research is to create an effective team training that can be rapidly scaled up and disseminated to rural CACs nationwide. Supporting rural teams can improve team performance, strengthen the workforce, and ultimately improve service quality and outcomes for rural children who experience child abuse.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Improving Teamwork in Rural Child Advocacy Centers: A Hybrid-Effectiveness Implementation Trial of TeamTRACS
Actual Study Start Date : June 8, 2022
Estimated Primary Completion Date : January 2023
Estimated Study Completion Date : January 2023

Arm Intervention/treatment
Experimental: TeamTRACS (Team Training in Roles, Awareness, Communication, and Support)
CACs randomized to the intervention condition (n = 4) will participate in TeamTRACS. CACs will receive an implementation guide to assist in preparing for and maximizing the impact of training.
Behavioral: TeamTRACS
TeamTRACS is a team training intervention adapted from TeamSTEPPS (Team Strategies and Tools to Enhance Performance and Patient Safety), a widely used evidence-based team training developed by the Agency for Healthcare Research and Quality. TeamTRACS targets knowledge, skills, and attitudes related to team member roles, shared awareness, communication, mutual support, and goal-setting. TeamTRACS is structured, easy to use, flexible in length and intensity, and requires few resources. It incorporates didactic instruction, discussion, and interactive activities and can be delivered virtually or in-person.

No Intervention: Waitlist Comparison
CACs randomized to the waitlist comparison (n = 2) will participate in TeamTRACS approximately 4 months after CACs in the intervention condition.



Primary Outcome Measures :
  1. Change in teamwork knowledge from baseline to 3-month follow-up [ Time Frame: Baseline, 3-month follow-up ]
    Survey questions assessing knowledge taught in TeamTRACS will be assessed with multiple choice questions. The percent of correct answers (range 0-100%) will be calculated.

  2. Change in teamwork skill use from baseline to 3-month follow-up [ Time Frame: Baseline, 3-month follow-up ]
    Frequency of teamwork skill use will be assessed with survey items rated on a 5-point Likert scale. Scores will be averaged; higher scores indicate more frequent skill use.

  3. Acceptability of self-guided implementation [ Time Frame: Baseline ]
    Perceived acceptability of the self-guided implementation process will be assessed with items from the Acceptability of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.

  4. Acceptability of self-guided implementation [ Time Frame: Month 4 ]
    Perceived acceptability of the self-guided implementation process will be assessed with items from the Acceptability of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.

  5. Acceptability of self-guided implementation [ Time Frame: Month 8 ]
    Perceived acceptability of the self-guided implementation process will be assessed with items from the Acceptability of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.

  6. Appropriateness of self-guided implementation [ Time Frame: Baseline ]
    Perceived appropriateness of the self-guided implementation process will be assessed with items from the Intervention Appropriateness Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.

  7. Appropriateness of self-guided implementation [ Time Frame: Month 4 ]
    Perceived appropriateness of the self-guided implementation process will be assessed with items from the Intervention Appropriateness Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.

  8. Appropriateness of self-guided implementation [ Time Frame: Month 8 ]
    Perceived appropriateness of the self-guided implementation process will be assessed with items from the Intervention Appropriateness Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.

  9. Feasibility of self-guided implementation [ Time Frame: Baseline ]
    Perceived feasibility of the self-guided implementation process will be assessed with items from the Feasibility of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.

  10. Feasibility of self-guided implementation [ Time Frame: Month 4 ]
    Perceived feasibility of the self-guided implementation process will be assessed with items from the Feasibility of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.

  11. Feasibility of self-guided implementation [ Time Frame: Month 8 ]
    Perceived feasibility of the self-guided implementation process will be assessed with items from the Feasibility of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions.


Secondary Outcome Measures :
  1. Change in team functioning from baseline to 3-month follow-up [ Time Frame: Baseline, 3-month follow-up ]
    Affective, behavioral, and cognitive processes and states will be assessed with survey items rated on Likert scales. Scores will be averaged; higher scores indicate more adaptive team functioning.

  2. Change in team performance from baseline to 3-month follow-up [ Time Frame: Baseline, 3-month follow-up ]
    The overall quality of work done by the team will be assessed with with Edmondson's (1999) Team Performance scale of 5 items rated on a 7-point Likert scale. Scores will be averaged; higher scores indicate better performance.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Individuals at least 18 years of age who are members of the multidisciplinary team at the participating CACs.

Exclusion Criteria:

  • Under 18 years old

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05370157


Locations
Layout table for location information
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
National Institutes of Health (NIH)
Investigators
Layout table for investigator information
Principal Investigator: Elizabeth A McGuier, PhD University of Pittsburgh
Layout table for additonal information
Responsible Party: Elizabeth McGuier, Assistant Professor of Psychiatry, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT05370157    
Other Study ID Numbers: STUDY21110090
UL1TR001857 ( U.S. NIH Grant/Contract )
First Posted: May 11, 2022    Key Record Dates
Last Update Posted: June 14, 2022
Last Verified: June 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Deidentified data will be available upon reasonable request as allowed by IRB regulations and after manuscripts reporting the main findings are accepted for publication.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Analytic Code
Time Frame: Data will be available after manuscripts reporting the main findings are accepted for publication.
Access Criteria: Contact the principal investigator to request access to the deidentified data.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Elizabeth McGuier, University of Pittsburgh:
multidisciplinary teamwork
implementation